Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-28

Clinical Trial Update: French Evaluation Group Avastin Versus Lucentis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Avastin to Lucentis for age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)
  • Lucentis (ranibizumab)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Age Related Macular Degeneration | Phase 3 | Status: COMPLETED